49,476 Shares in Nutrien Ltd. $NTR Purchased by Quantitative Investment Management LLC

Quantitative Investment Management LLC bought a new position in shares of Nutrien Ltd. (NYSE:NTR) during the second quarter, Holdings Channel reports. The fund bought 49,476 shares of the company’s stock, valued at approximately $3,114,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Nutrien by 65.1% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,224 shares of the company’s stock valued at $1,253,000 after buying an additional 9,950 shares during the period. NewEdge Advisors LLC lifted its holdings in Nutrien by 6.2% in the first quarter. NewEdge Advisors LLC now owns 6,907 shares of the company’s stock valued at $343,000 after acquiring an additional 404 shares during the last quarter. Focus Partners Wealth purchased a new position in Nutrien in the first quarter worth approximately $516,000. Acadian Asset Management LLC purchased a new position in Nutrien in the first quarter worth approximately $54,000. Finally, Prudential Financial Inc. acquired a new stake in Nutrien during the second quarter worth $203,000. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on NTR shares. Wall Street Zen downgraded Nutrien from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. UBS Group lowered their price target on Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a report on Monday, May 11th. Weiss Ratings raised Nutrien from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, August 6th. Morgan Stanley reduced their price objective on shares of Nutrien from $93.00 to $81.00 and set an “overweight” rating on the stock in a report on Tuesday, July 7th. Finally, TD Securities reaffirmed a “buy” rating on shares of Nutrien in a research report on Wednesday, May 6th. Seventeen investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $81.58.

Nutrien Stock Up 0.2%

Nutrien stock opened at $73.64 on Monday. Nutrien Ltd. has a fifty-two week low of $53.03 and a fifty-two week high of $85.36. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.86 and a current ratio of 1.39. The firm has a 50 day moving average price of $67.33 and a 200 day moving average price of $70.57. The company has a market capitalization of $35.23 billion, a PE ratio of 14.91, a price-to-earnings-growth ratio of 0.78 and a beta of 0.61.

Nutrien (NYSE:NTR) last announced its earnings results on Wednesday, August 5th. The company reported $2.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.70 by ($0.09). Nutrien had a net margin of 8.44% and a return on equity of 8.88%. The firm had revenue of $10.81 billion during the quarter, compared to analysts’ expectations of $10.44 billion. During the same period in the previous year, the firm earned $2.65 EPS. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. Research analysts expect that Nutrien Ltd. will post 4.71 earnings per share for the current year.

Nutrien Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 16th. Investors of record on Tuesday, September 29th will be paid a dividend of $0.55 per share. The ex-dividend date of this dividend is Tuesday, September 29th. This represents a $2.20 annualized dividend and a yield of 3.0%. Nutrien’s dividend payout ratio is presently 44.53%.

Nutrien News Summary

Here are the key news stories impacting Nutrien this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $4.38 from $3.66, a substantial improvement that suggests stronger expected profitability. The firm also lifted estimates for Q2 2027, Q4 2027, FY2026, FY2028, Q1 2027, Q3 2027, Q4 2026 and Q2 2028. Collectively, the revisions point to improving longer-term earnings expectations.
• Positive Sentiment: An investor article emphasizes the appeal of not missing another year of Nutrien’s dividend income, which may reinforce the stock’s attraction to income-oriented investors. You’ve Already Missed a Year of Dividends: Here’s Why I Wouldn’t Miss Another
• Neutral Sentiment: Nutrien’s estimated current-year EPS remains below the broader consensus at $4.71 versus $4.95, while FY2027 and FY2028 estimates are $4.38 and $4.23, respectively. This indicates improving expectations but not an across-the-board bullish outlook.
• Negative Sentiment: Zacks Research reduced its Q3 2026 EPS estimate to $0.78 from $0.92 and its Q1 2028 estimate to $0.63 from $0.76. These cuts signal potential near-term earnings pressure and could limit the stock’s upside.

Nutrien Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.